• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors.

作者信息

Ugurlu Serdal, Akcin Ruveyda, Ayla Ali Yagiz, Kocazeybek Bekir, Oztas Mert, Can Gunay, Mustafayeva Leyla, Saltoglu Nese, Yilmaz Betul, Ozdogan Huri

机构信息

Division of Rheumatology, Department of Internal Medicine.

Department of Medical Microbiology.

出版信息

Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI194-SI196. doi: 10.1093/rheumatology/keac123.

DOI:10.1093/rheumatology/keac123
PMID:35258567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9383560/
Abstract
摘要

相似文献

1
Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors.接受白细胞介素-1抑制剂治疗的家族性地中海热患者对灭活和mRNA新冠疫苗的抗体反应。
Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI194-SI196. doi: 10.1093/rheumatology/keac123.
2
Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever.家族性地中海热患者中严重急性呼吸综合征冠状病毒 2 感染的临床影响和疾病演变。
Pharmacol Res. 2022 Aug;182:106293. doi: 10.1016/j.phrs.2022.106293. Epub 2022 Jun 9.
3
Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19.mRNA疫苗和灭活疫苗针对新型冠状病毒肺炎的免疫原性比较
Lancet Microbe. 2021 Sep;2(9):e423. doi: 10.1016/S2666-5247(21)00177-4. Epub 2021 Jul 16.
4
Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine.白塞病和家族性地中海热患者接种新型冠状病毒疫苗的安全性：基于信使核糖核酸疫苗和灭活疫苗效果的横断面比较研究
Rheumatol Int. 2022 Jun;42(6):973-987. doi: 10.1007/s00296-022-05119-y. Epub 2022 Apr 4.
5
Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies.接受疾病修饰治疗的多发性硬化症患者接种两剂mRNA疫苗和灭活疫苗后SARS-CoV-2抗体反应的比较。
Mult Scler Relat Disord. 2022 Feb;58:103486. doi: 10.1016/j.msard.2022.103486. Epub 2022 Jan 10.
6
COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study.COVID-19 患者中家族性地中海热的结局：一项回顾性队列研究。
Rheumatol Int. 2021 Apr;41(4):715-719. doi: 10.1007/s00296-021-04812-8. Epub 2021 Feb 21.
7
Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.腹膜透析和血液透析患者对 SARS-CoV-2 mRNA 疫苗的长期抗体反应比较。
Nephrol Dial Transplant. 2022 Feb 25;37(3):602-604. doi: 10.1093/ndt/gfab321.
8
Blunted humoral response after mRNA vaccine in patients with haematological malignancies.血液系统恶性肿瘤患者接种mRNA疫苗后体液免疫反应减弱。
Lancet Haematol. 2021 Aug;8(8):e540-e542. doi: 10.1016/S2352-3026(21)00197-6. Epub 2021 Jul 2.
9
Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.针对多发性硬化症患者的 SARS-CoV-2 灭活疫苗和 mRNA 疫苗的安全性和体液免疫应答率。
Mult Scler Relat Disord. 2022 Mar;59:103690. doi: 10.1016/j.msard.2022.103690. Epub 2022 Feb 13.
10
Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.评估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗（BNT126b2）在维持性血液透析患者中的细胞免疫原性和体液免疫原性。
EBioMedicine. 2021 Sep;71:103567. doi: 10.1016/j.ebiom.2021.103567. Epub 2021 Aug 26.

引用本文的文献

1
Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors.自身炎症性疾病与新冠疫苗接种：一组接受白细胞介素-1抑制剂治疗患者的严重急性呼吸综合征冠状病毒2抗刺突蛋白受体结合域免疫球蛋白G水平分析
J Clin Med. 2023 Jul 18;12(14):4741. doi: 10.3390/jcm12144741.
2
Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases.小儿及成人系统性自身炎症性疾病患者疫苗接种的当前证据
Vaccines (Basel). 2023 Jan 10;11(1):151. doi: 10.3390/vaccines11010151.

本文引用的文献

1
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong.比较香港科兴和国药新冠疫苗的免疫原性。
Respirology. 2022 Apr;27(4):301-310. doi: 10.1111/resp.14191. Epub 2021 Nov 24.
2
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19.白细胞介素-1和白细胞介素-6抑制作用会影响新型冠状病毒肺炎患者体内抗严重急性呼吸综合征冠状病毒2抗体的中和活性。
Lancet Rheumatol. 2021 Dec;3(12):e829-e831. doi: 10.1016/S2665-9913(21)00321-0. Epub 2021 Oct 29.
3
COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics.新型冠状病毒肺炎与自身炎症性疾病：生物制剂治疗患者的感染患病率及转归以及疫苗接种早期经验
Rheumatol Adv Pract. 2021 Aug 23;5(2):rkab043. doi: 10.1093/rap/rkab043. eCollection 2021.
4
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.美国风湿病学会关于风湿和肌肉骨骼疾病患者 COVID-19 疫苗接种的指南：第 3 版。
Arthritis Rheumatol. 2021 Oct;73(10):e60-e75. doi: 10.1002/art.41928. Epub 2021 Aug 4.
5
Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever.家族性地中海热患者 COVID-19 住院的发生率和病程。
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI85-SI89. doi: 10.1093/rheumatology/keab577.
6
Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.亚太风湿病学会联盟关于 COVID-19 大流行期间风湿病患者管理的共识更新声明。
Int J Rheum Dis. 2021 Jun;24(6):733-745. doi: 10.1111/1756-185X.14124. Epub 2021 May 4.
7
The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response.托珠单抗、阿那白滞素和泼尼松龙对 COVID-19 患者抗 SARS-CoV-2 抗体反应的影响：一项前瞻性队列研究，采用多变量分析影响抗体反应的因素。
Int J Infect Dis. 2021 Apr;105:756-762. doi: 10.1016/j.ijid.2021.03.031. Epub 2021 Mar 15.
8
Influenza and meningococcal vaccinations are effective in healthy subjects treated with the interleukin-1 beta-blocking antibody canakinumab: results of an open-label, parallel group, randomized, single-center study.流感疫苗和脑膜炎球菌疫苗对接受白细胞介素-1β阻断抗体卡那单抗治疗的健康受试者有效：一项开放标签、平行组、随机、单中心研究的结果。
Clin Vaccine Immunol. 2010 Dec;17(12):1952-7. doi: 10.1128/CVI.00175-10. Epub 2010 Oct 20.